Anzeige
Mehr »
Login
Donnerstag, 23.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Mit dieser Aktie könntest Du von der Cannabis-Legalisierungswelle profitieren!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DFJP | ISIN: US65345B2016 | Ticker-Symbol:
NASDAQ
22.05.24
17:36 Uhr
1,110 US-Dollar
-0,070
-5,93 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
NEXALIN TECHNOLOGY INC Chart 1 Jahr
5-Tage-Chart
NEXALIN TECHNOLOGY INC 5-Tage-Chart

Aktuelle News zur NEXALIN TECHNOLOGY Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiNexalin Technology, Inc.: Nexalin America Selected to Join the National Traumatic Brain Injury Registry Coalition to Propel TBI Awareness and Research Efforts1
DiNexalin Technology, Inc. - 8-K, Current Report1
10.05.Nexalin Technology, Inc. - 10-Q, Quarterly Report2
25.04.Nexalin Technology regains compliance with Nasdaq continued listing requirements1
25.04.Nexalin Technology, Inc.: Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements124HOUSTON, TEXAS, April 25, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the "Company" or "Nexalin") (Nasdaq: NXL; NXLIW) announced that the Company received notice from The Nasdaq Stock Market...
► Artikel lesen
19.04.Pre-market Movers: Zhongchao, Redwoods Acquisition Corp., Tritium DCFC, Nexalin Technology, Sunshine Biopharma437CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 08.05 A.M. ET).In the Green Zhongchao Inc. (ZCMD) is up over 96% at $2.83. Redwoods...
► Artikel lesen
16.04.Nexalin Technology files to offer common stock worth $5.65M1
11.04.Nexalin Technology, Inc. - 8-K, Current Report1
04.04.Nexalin Technology, Inc.: Nexalin Technology Awarded Key Patent Related to its Gen-3 HALO Clarity, a Non-Invasive, Frequency-Based Deep-Brain Stimulation Device102HOUSTON, TX, April 04, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the "Company" or "Nexalin") (Nasdaq: NXL; NXLIW) today announced that the United States Patent and Trademark Office (USPTO)...
► Artikel lesen
02.04.Nexalin Technology, Inc.: Nexalin Technology Announces the Appointment of Government Affairs Veteran William A. Hudson, Jr. to Military & Government Advisory Board4
27.03.Nexalin Technology, Inc. - 10-K, Annual Report2
20.03.Nexalin Technology, Inc. - 8-K, Current Report1
14.03.Nexalin Technology commences sales of gen-2 neurostimulation device in Oman2
14.03.Nexalin Technology, Inc.: Nexalin Technology Commences Sales of Gen-2 Neurostimulation Device to New Mental Health Center in Oman Dedicated to Nexalin's Technology338HOUSTON, TEXAS, March 14, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the "Company" or "Nexalin") (Nasdaq: NXL; NXLIW) today announced that it has commenced sales of its second generation (Gen-2)...
► Artikel lesen
13.03.Nexalin Technology, Inc.: Nexalin Technology Announces Poster Presentation at "State of the Technology Meeting: Neurotrauma Diagnosis, Monitoring, and Assessment"1
06.03.Nexalin rises on positive data for sleep disorder treatment device1
06.03.Nexalin Technology, Inc.: Nexalin Technology Announces Positive Results from Clinical Study of its Gen-2 tACS Device for Treating Adult Patients with Chronic Insomnia135Clinical study demonstrated clinically meaningful and statistically significant improvements in key sleep parameters, compared to adult patients treated with placeboData published in Journal of Psychiatric...
► Artikel lesen
08.02.Oman approves Nexalin's neurostimulation device-
08.02.Nexalin Technology, Inc.: Nexalin Technology Announces Regulatory Approval in Oman for Gen-2 Neurostimulation Device336HOUSTON, TEXAS, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the "Company" or "Nexalin") (Nasdaq: NXL; NXLIW) today announced that its second generation (Gen-2), 15 milliamp (mA) neurostimulation...
► Artikel lesen
23.01.Nexalin Technology, Inc.: Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device - the Transcranial Alternating Current Dynamic Frequency Stimulation (TACS) System1
Seite:  Weiter >>
22 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1